A General Overview of Mesenchymal Stem Cell Therapies in Drug- and Chemical-Induced Liver Injury Models
-
Published:2024-04-01
Issue:2
Volume:35
Page:212-221
-
ISSN:1300-056X
-
Container-title:Gazi Medical Journal
-
language:
-
Short-container-title:GMJ
Author:
Ceyhan Müşerref ŞeymaORCID,
Ömeroğlu SunaORCID,
Yığman ZeynepORCID
Publisher
Galenos Yayinevi
Reference55 articles.
1. Risk factors for idiosyncratic drug-induced liver injury;Chalasani;Gastroenterology,2010
2. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET];Fernandez-Checa;J Hepatol,2021
3. Phenotypes and Pathology of Drug-Induced Liver Disease;Goodman;Clin Liver Dis,2017
4. 4. Perera MT, Mirza DF, Elias E. Liver transplantation: Issues for the next 20 years. J Gastroenterol Hepatol 2009; 24(Suppl 3): S124-31.
5. 5. Toti L, Manzia TM, Sensi B, Blasi F, Baiocchi L, Lenci I, et al. Towards tolerance in liver transplantation. Best Pract Res Clin Gastroenterol 2021; 54-55: 101770.